Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production.
Kerstholt M, van de Schoor FR, Oosting M, Moorlag SJCFM, Li Y, Jaeger M, van der Heijden WA, Tunjungputri RN, Dos Santos JC, Kischkel B, Vrijmoeth HD, Baarsma ME, Kullberg BJ, Lupse M, Hovius JW, van den Wijngaard CC, Netea MG, de Mast Q, Joosten LAB. Kerstholt M, et al. Among authors: van den wijngaard cc. Clin Exp Immunol. 2022 Oct 21;210(1):53-67. doi: 10.1093/cei/uxac073. Clin Exp Immunol. 2022. PMID: 36001729 Free PMC article.
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
Vrijmoeth HD, Ursinus J, Harms MG, Zomer TP, Gauw SA, Tulen AD, Kremer K, Sprong H, Knoop H, Vermeeren YM, van Kooten B, Joosten LAB, Kullberg BJ, Hovius JWR, van den Wijngaard CC. Vrijmoeth HD, et al. Among authors: van den wijngaard cc, van kooten b. BMC Infect Dis. 2019 Apr 15;19(1):324. doi: 10.1186/s12879-019-3949-8. BMC Infect Dis. 2019. PMID: 30987580 Free PMC article.
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.
Ursinus J, Vrijmoeth HD, Harms MG, Tulen AD, Knoop H, Gauw SA, Zomer TP, Wong A, Friesema IHM, Vermeeren YM, Joosten LAB, Hovius JW, Kullberg BJ, van den Wijngaard CC. Ursinus J, et al. Among authors: van den wijngaard cc. Lancet Reg Health Eur. 2021 May 27;6:100142. doi: 10.1016/j.lanepe.2021.100142. eCollection 2021 Jul. Lancet Reg Health Eur. 2021. PMID: 34557833 Free PMC article.
Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.
van de Schoor FR, Vrijmoeth HD, Brouwer MAE, Ter Hofstede HJM, Lemmers HLM, Dijkstra H, Boahen CK, Oosting M, Kullberg BJ, Hovius JW, van den Wijngaard CC, van de Veerdonk FL, Netea MG, Joosten LAB. van de Schoor FR, et al. Among authors: van den wijngaard cc, van de veerdonk fl. Infect Immun. 2022 Mar 17;90(3):e0055821. doi: 10.1128/iai.00558-21. Epub 2022 Feb 7. Infect Immun. 2022. PMID: 35130450 Free PMC article.
Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors´ reply.
van den Wijngaard CC, Ursinus J, Vrijmoeth HD, Knoop H, Wong A, Joosten LAB, Hovius JW, Kullberg BJ. van den Wijngaard CC, et al. Lancet Reg Health Eur. 2022 Mar 22;15:100344. doi: 10.1016/j.lanepe.2022.100344. eCollection 2022 Apr. Lancet Reg Health Eur. 2022. PMID: 35342893 Free PMC article. No abstract available.
Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study.
Baarsma ME, van de Schoor FR, Gauw SA, Vrijmoeth HD, Ursinus J, Goudriaan N, Popa CD, Ter Hofstede HJ, Leeflang MM, Kremer K, van den Wijngaard CC, Kullberg BJ, Joosten LA, Hovius JW. Baarsma ME, et al. Among authors: van den wijngaard cc, van de schoor fr. Lancet Infect Dis. 2022 Sep;22(9):1388-1396. doi: 10.1016/S1473-3099(22)00205-5. Epub 2022 Jun 14. Lancet Infect Dis. 2022. PMID: 35714662
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].
Ursinus J, Vrijmoeth HD, Harms MG, Tulen AD, Knoop H, Gauw SA, Zomer TP, Wong A, Friesema IHM, Vermeeren YM, Joosten LAB, Hovius JW, Kullberg BJ, van den Wijngaard CC. Ursinus J, et al. Among authors: van den wijngaard cc. Lancet Reg Health Eur. 2023 Mar 15;27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr. Lancet Reg Health Eur. 2023. PMID: 36968322 Free PMC article.
Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.
Vrijmoeth HD, Ursinus J, Harms MG, Tulen AD, Baarsma ME, van de Schoor FR, Gauw SA, Zomer TP, Vermeeren YM, Ferreira JA, Sprong H, Kremer K, Knoop H, Joosten LAB, Kullberg BJ, Hovius JW, van den Wijngaard CC. Vrijmoeth HD, et al. Among authors: van den wijngaard cc. EBioMedicine. 2023 Dec;98:104825. doi: 10.1016/j.ebiom.2023.104825. Epub 2023 Nov 27. EBioMedicine. 2023. PMID: 38016860 Free PMC article.
Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires.
van de Schoor FR, Baarsma ME, Gauw SA, Ursinus J, Vrijmoeth HD, Ter Hofstede HJM, Tulen AD, Harms MG, Wong A, van den Wijngaard CC, Joosten LAB, Hovius JW, Kullberg BJ. van de Schoor FR, et al. Among authors: van den wijngaard cc. Eur J Clin Microbiol Infect Dis. 2024 Mar 16. doi: 10.1007/s10096-024-04770-6. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38492058
57 results